Yumi Mizuno

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease　- Evidence for a Potentially Protective Role.

Journal: Circulation reports

Published: January 29, 2025

Genome Analysis of Japanese Yersinia pseudotuberculosis Strains Isolated From Kawasaki Disease Patients and Other Sources and Their Phylogenetic Positions in the Global Y. pseudotuberculosis Population.

Journal: Microbiology and immunology

Published: September 19, 2024

Respiratory viral infections and Kawasaki disease: A molecular epidemiological analysis.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: November 27, 2023

CD14 down-modulation as a real-time biomarker in Kawasaki disease.

Journal: Clinical & translational immunology

Published: October 02, 2023

Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan.

Journal: The Pediatric infectious disease journal

Published: February 02, 2023

Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.

Journal: Brain & development

Published: April 18, 2022

Case Report: Acute Fulminant Cerebral Edema With Perivascular Abnormalities Related to Kawasaki Disease.

Journal: Frontiers in pediatrics

Published: June 28, 2021

Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.

Journal: Vaccines

Published: May 27, 2021

The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: April 28, 2021

Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.

Journal: JAMA network open

Published: April 06, 2021

Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.

Journal: The Journal of pediatrics

Published: April 28, 2020

Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies.

Journal: Frontiers in immunology

Published: November 30, 2019

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease - Evidence for a Potentially Protective Role.

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease - Evidence for a Potentially Protective Role.

Genome Analysis of Japanese Yersinia pseudotuberculosis Strains Isolated From Kawasaki Disease Patients and Other Sources and Their Phylogenetic Positions in the Global Y. pseudotuberculosis Population.

Genome Analysis of Japanese Yersinia pseudotuberculosis Strains Isolated From Kawasaki Disease Patients and Other Sources and Their Phylogenetic Positions in the Global Y. pseudotuberculosis Population.

Respiratory viral infections and Kawasaki disease: A molecular epidemiological analysis.

Respiratory viral infections and Kawasaki disease: A molecular epidemiological analysis.

CD14 down-modulation as a real-time biomarker in Kawasaki disease.

CD14 down-modulation as a real-time biomarker in Kawasaki disease.

Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan.

Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan.

Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.

Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.

Case Report: Acute Fulminant Cerebral Edema With Perivascular Abnormalities Related to Kawasaki Disease.

Case Report: Acute Fulminant Cerebral Edema With Perivascular Abnormalities Related to Kawasaki Disease.

Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.

Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.

The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.

Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.

Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.

Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.

Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies.

Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies.

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease　- Evidence for a Potentially Protective Role.

Anti-Oxidized Low-Density Lipoprotein Antibodies Before and After Intravenous Immunoglobulin Therapy in Kawasaki Disease　- Evidence for a Potentially Protective Role.